MX360479B - Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. - Google Patents
Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.Info
- Publication number
- MX360479B MX360479B MX2015004271A MX2015004271A MX360479B MX 360479 B MX360479 B MX 360479B MX 2015004271 A MX2015004271 A MX 2015004271A MX 2015004271 A MX2015004271 A MX 2015004271A MX 360479 B MX360479 B MX 360479B
- Authority
- MX
- Mexico
- Prior art keywords
- ibs
- markers
- microbiome
- antibodies
- mast cell
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261710574P | 2012-10-05 | 2012-10-05 | |
| US201361871853P | 2013-08-29 | 2013-08-29 | |
| PCT/IB2013/059045 WO2014053996A2 (en) | 2012-10-05 | 2013-10-01 | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015004271A MX2015004271A (es) | 2015-08-14 |
| MX360479B true MX360479B (es) | 2018-11-05 |
Family
ID=49447585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015004271A MX360479B (es) | 2012-10-05 | 2013-10-01 | Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10184940B2 (enExample) |
| EP (1) | EP2904395B1 (enExample) |
| JP (1) | JP6329553B2 (enExample) |
| CN (1) | CN104884959B (enExample) |
| AU (1) | AU2013326133B2 (enExample) |
| CA (1) | CA2886991A1 (enExample) |
| MX (1) | MX360479B (enExample) |
| SG (2) | SG11201502641YA (enExample) |
| WO (1) | WO2014053996A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0720250D0 (en) | 2007-10-17 | 2007-11-28 | Univ Edinburgh | Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| MX2015015844A (es) * | 2013-05-17 | 2016-03-04 | Basf Se | Proceso para preparar compuestos n-sustituidos de acido 1h-pirazol-5-carboxilico y sus derivados. |
| CA2913108A1 (en) | 2013-05-24 | 2014-11-27 | Nestec S.A. | Pathway specific assays for predicting irritable bowel syndrome diagnosis |
| WO2017079653A2 (en) * | 2015-11-06 | 2017-05-11 | Vetica Labs, Inc. | Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals |
| EP3421616A1 (en) * | 2017-06-29 | 2019-01-02 | Tata Consultancy Services Limited | Method and system for monitoring the gut health of an individual |
| AU2018346255A1 (en) * | 2017-10-03 | 2020-04-23 | Seres Therapeutics, Inc. | Manipulation of tryptamine metabolism |
| JP6533930B1 (ja) * | 2018-08-23 | 2019-06-26 | 一般社団法人日本農業フロンティア開発機構 | 疾病評価指標算出方法、装置、システム、及び、プログラム、並びに、疾病評価指標を算出するためのモデル作成方法。 |
| US11884958B2 (en) | 2019-04-30 | 2024-01-30 | Mayo Foundation For Medical Education And Research | Assessing and treating functional gastrointestinal disorders |
| WO2025071560A1 (en) * | 2023-09-28 | 2025-04-03 | Rutgers, The State University Of New Jersey | Methods of diagnosing b cell malignancies, detecting b cell malignancy relapse, and treating thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070275424A1 (en) * | 2002-11-22 | 2007-11-29 | Andrew Gewirtz | Diagnostic Tests and Methods for Diagnosing Inflammatory Bowel Disease |
| US20060154276A1 (en) | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US7943328B1 (en) * | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
| US20100094560A1 (en) * | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20080085524A1 (en) | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| WO2011027971A2 (ko) * | 2009-09-01 | 2011-03-10 | 주식회사이언메딕스 | 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법 |
| JP2013509593A (ja) * | 2009-10-30 | 2013-03-14 | ネステク ソシエテ アノニム | 過敏性腸症候群の診断方法 |
-
2013
- 2013-10-01 MX MX2015004271A patent/MX360479B/es active IP Right Grant
- 2013-10-01 CN CN201380063446.2A patent/CN104884959B/zh not_active Expired - Fee Related
- 2013-10-01 JP JP2015535149A patent/JP6329553B2/ja not_active Expired - Fee Related
- 2013-10-01 CA CA2886991A patent/CA2886991A1/en not_active Abandoned
- 2013-10-01 SG SG11201502641YA patent/SG11201502641YA/en unknown
- 2013-10-01 WO PCT/IB2013/059045 patent/WO2014053996A2/en not_active Ceased
- 2013-10-01 EP EP13779635.5A patent/EP2904395B1/en not_active Not-in-force
- 2013-10-01 AU AU2013326133A patent/AU2013326133B2/en not_active Expired - Fee Related
- 2013-10-01 SG SG10201702773QA patent/SG10201702773QA/en unknown
-
2015
- 2015-03-30 US US14/673,660 patent/US10184940B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104884959B (zh) | 2017-12-01 |
| CA2886991A1 (en) | 2014-04-10 |
| AU2013326133B2 (en) | 2019-07-04 |
| SG11201502641YA (en) | 2015-05-28 |
| HK1213050A1 (en) | 2016-06-24 |
| AU2013326133A1 (en) | 2015-04-23 |
| CN104884959A (zh) | 2015-09-02 |
| US20150346200A1 (en) | 2015-12-03 |
| EP2904395A2 (en) | 2015-08-12 |
| EP2904395B1 (en) | 2018-09-05 |
| JP2015533213A (ja) | 2015-11-19 |
| WO2014053996A3 (en) | 2014-05-30 |
| WO2014053996A2 (en) | 2014-04-10 |
| SG10201702773QA (en) | 2017-06-29 |
| US10184940B2 (en) | 2019-01-22 |
| MX2015004271A (es) | 2015-08-14 |
| JP6329553B2 (ja) | 2018-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014053996A3 (en) | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs | |
| HK1223361A1 (zh) | 用於预测肠易激综合征诊断的途径特异性测定 | |
| NZ628458A (en) | Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis | |
| EA201600085A1 (ru) | Набор для обнаружения соевого события syht0h2 | |
| EP4060048A3 (en) | Non-invasive diagnostic method for diagnosing bladder cancer | |
| MX355416B (es) | Biomarcadores de cancer de pulmon y usos de los mismos. | |
| WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
| EP2576833A4 (en) | METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE | |
| MX358541B (es) | Metodos para predecir el riesgo de desarrollar hipertension. | |
| WO2014028378A3 (en) | Methods and systems for detecting biological components | |
| MX2013005067A (es) | Receptor alfa de folato como marcador de diagnostico y pronostico para canceres que expresan receptor alfa de folato. | |
| HK1199099A1 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
| BR112014031365A2 (pt) | métodos de detectar doenças ou condições | |
| EA201391187A1 (ru) | Способ диагностики злокачественной опухоли и набор для диагностики путем измерения активности nk-клеток | |
| GB2511221A (en) | Methods and compositions for classification of samples | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| WO2016198833A3 (en) | Methods for analysing a urine sample | |
| MX2015001961A (es) | Metodos y sistemas para ensayos. | |
| WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
| HK1204061A1 (en) | Methods and kits for detecting and diagnosing neurotrauma | |
| MX381530B (es) | Método in vitro para el diagnóstico de la enfermedad de niemann-pick. | |
| NZ729773A (en) | Biomarkers for disease progression in melanoma | |
| GB2552271A (en) | A method for diagnosing lung cancer | |
| WO2011130647A3 (en) | Compositions and methods for characterizing a myopathy | |
| WO2014153232A3 (en) | Methods and compositions for diagnosing preeclampsia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |